Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Sobue

Showing results (471-480 of 576) with videos related to

Pageof 58
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 5, 2014
Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulationTakashi Tsuboi, Hirohisa Watanabe, Yasuhiro Tanaka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.
Annals of Neurology|January 26, 2005
Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosisYue-Mei Jiang, Masahiko Yamamoto, Yasushi Kobayashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 30, 2016
Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuumMichihito Masuda, Joe Senda, Hirohisa Watanabe, et al.
Nagoya Journal of Medical Science|December 29, 2023
＜Editors' Choice＞ Pattern of THK 5351 retention in normal aging involves core regions of resting state networks associated with higher cognitive functionYusuke Yoshida, Takamasa Yokoi, Kazuhiro Hara, et al.
The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.
Annals of Clinical and Translational Neurology|October 22, 2020
The neural network basis of altered decision-making in patients with amyotrophic lateral sclerosisKazunori Imai, Michihito Masuda, Hirohisa Watanabe, et al.
Annals of Clinical and Translational Neurology|July 8, 2016
Impaired muscle uptake of creatine in spinal and bulbar muscular atrophyYasuhiro Hijikata, Masahisa Katsuno, Keisuke Suzuki, et al.
Scientific Reports|August 26, 2016
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's diseaseKyota Fujita, Kazumi Motoki, Kazuhiko Tagawa, et al.
Neurobiology of Aging|June 26, 2012
Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosisKotaro Ogaki, Yuanzhe Li, Naoki Atsuta, et al.
Pageof 58

Showing results (471-480 of 576) with videos related to

Sort By:
Pageof 58
Journal of Neurology, Neurosurgery, and Psychiatry|October 5, 2014
Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulationTakashi Tsuboi, Hirohisa Watanabe, Yasuhiro Tanaka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.
Annals of Neurology|January 26, 2005
Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosisYue-Mei Jiang, Masahiko Yamamoto, Yasushi Kobayashi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 30, 2016
Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuumMichihito Masuda, Joe Senda, Hirohisa Watanabe, et al.
Nagoya Journal of Medical Science|December 29, 2023
＜Editors' Choice＞ Pattern of THK 5351 retention in normal aging involves core regions of resting state networks associated with higher cognitive functionYusuke Yoshida, Takamasa Yokoi, Kazuhiro Hara, et al.
The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.
Annals of Clinical and Translational Neurology|October 22, 2020
The neural network basis of altered decision-making in patients with amyotrophic lateral sclerosisKazunori Imai, Michihito Masuda, Hirohisa Watanabe, et al.
Annals of Clinical and Translational Neurology|July 8, 2016
Impaired muscle uptake of creatine in spinal and bulbar muscular atrophyYasuhiro Hijikata, Masahisa Katsuno, Keisuke Suzuki, et al.
Scientific Reports|August 26, 2016
HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's diseaseKyota Fujita, Kazumi Motoki, Kazuhiko Tagawa, et al.
Neurobiology of Aging|June 26, 2012
Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosisKotaro Ogaki, Yuanzhe Li, Naoki Atsuta, et al.
Pageof 58